Patent Eligibility Reform and the Public Health
نویسندگان
چکیده
منابع مشابه
Regulatory reform proposals and the public health.
The U.S. Congress is considering legislation that would change policy for environmental health in important ways. Current approaches have been criticized for addressing the wrong set of priorities and consuming too many resources. The legislation requires additional analyses and sets new decision criteria to be applied to federal agency actions taken to protect the environment and public health...
متن کاملIdentification of Public Policy Implementation Barriers (Health System Reform Plan)
Background & Aims of the Study: One of the main concerns of policymakers is the establishment of health equity and access to health services. Health system reform plan is one of the most important tools of policy makers in the health system. The health system, as any other plan has had some problems during implementation. Therefore, the purpose of this study is to identify the obstacles to the ...
متن کاملHealthcare Reform ≠ Public Health Reform: On Pathogens, Poverty, and Prevention
Few would deny the contentiousness of the ongoing healthcare reform debate in the United States. Referencing the Patient Protection and Affordable Care Act (P.L. 111–148), a recent article in Foreign Affairs noted that ‘‘no U.S. law has been more passionately opposed by Republicans.’’ Unsuccessful efforts to replace or repeal the Act keep coming, proposed and then voted down or withdrawn during...
متن کاملPublic Health in the Age of Health Care Reform
Preventive medicine has vast unused possibilities for improving the health of the population, partly in ways that require compulsory controls, like quarantine and compulsory immunization, partly through systematic arrangements for personal check-ups and early diagnosis and treatment. Without going into the controversial question of socialized medicine, it is clear that health is a national asse...
متن کاملPatent-eligibility of Plants in Europe
The patent-eligibility of plants has been unsettled at the European Patent Office for some 20 years. Article 53(b) EPC prohibits the patenting of plant varieties and essentially biological processes for the production of plants. When other requirements such as novelty and inventive step are met, this causes few problems for transgenic plants modified by biotechnological methods, but it has been...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Milbank Quarterly
سال: 2019
ISSN: 0887-378X,1468-0009
DOI: 10.1111/1468-0009.12408